EGID Monothematic Conference

General Information

General Information

Eosinophilic gastrointestinal diseases (EGIDs) are rare chronic, inflammatory disorders of the gastrointestinal (GI) tract with unknown long-term consequences. They comprise of eosinophilic esophagitis (EoE), eosinophilic gastritis (EG), eosinophilic gastroenteritis (EGE) and eosinophilic colitis (EC). EoE is the most common and the best described EGID compared to EG, EGE and EC.  The clinical presentation of different EGIDs depends on the involved GI site as well as the extent and the depth of eosinophilic infiltration through the bowel wall.

In the absence of biological markers, the diagnosis is based on clinical symptoms and on histological findings of eosinophilic inflammation, after the exclusion of a secondary cause of inflammation or a systemic disorder, which is often a challenging issue given the absence of strict histological criteria for the EGIDs (beyond the esophagus) diagnosis. Treatment strategies depend on the involved site of the GI tract, maintenance therapy is often necessary to avoid relapses, while novel drugs are beeing developed for refractory disease. Due to the complexity of these disorders, the investigation and management of patients with EGIDs are often perplexing.
The Monothematic Conference on EGIDs will include invited lectures with physical presence of the speakers and few through web, as well as interactive sessions with cases presentations. The faculty comprise international experts in the field with different backgrounds and specific interests, aiming at enlightening different aspects of this challenging topic in order to aid clinicians of different specialties dealing with patients with EGIDs, to interpret the clinical manifestations and the laboratory findings of different EGIDs and to choose the best available treatment option, decreasing variations in clinical practice and improving effectiveness and quality of care.
The course language is English.

The EGID Monthematic Conference has been granted 17 European CME credits (ECMEC®s) by the European Accreditation Council for Continuing Medical Education (EACCME®)

COVID-19 Information

COVID-19 has proven challenging in the organisation of onsite courses in the past year. ESPGHAN remains dedicated to the realisation of our educational programme without compromising the health of our delegates.
We are carefully monitoring the developments and follow the recommendations and information provided by the national Health Authorities, the World Health Organization (WHO) and the European Centre for Disease Prevention and Control (ECDC). Preparations for an onsite course are proceeding as planned at this point. Applicants will be updated on any potential changes to the format of the school. 

If the situation does not allow for the responsible realisation of onsite participation, your application will be valid for virtual participation and registration fees will be reimbursed or adapted accordingly. 

In accordance with ESPGHAN Rules and Regulations non-members can only attend 1 educational event. Due to the Covid19 pandemic this rule is suspended until further notice.

For more information please contact the ESPGHAN Office.


Application & Fees

Applications are closed

Applications Deadline:  30/09/2021 23:30 CEST

Registration fees:

EUR 100 (Whole course) ESPGHAN Trainee member 
EUR 100 (Whole course) ESPGHAN Full member
EUR 200 (Whole course) Non-ESPGHAN member 

Application process: The number of participants is limited and a selection will be made by the school organisers after the deadline. Applicants will be selected upon their CV and a support letter from an ESPGHAN member (or their supervisor) if they are non ESPGHAN members. Priority will be given to ESPGHAN Members.

Kindly use the online application form on this page. Applications submitted by email cannot be accepted. If you experience any issues with the tool, please contact us at office@espghan

Please do not make travel arrangements before receipt of a formal confirmation of acceptance from the ESPGHAN Office. 


Preliminary Programme (Athens local time)

Day 01 - Thursday, November 04

Chairs: Alexandra Papadopoulou; Noam Zevit

08.45 – 09.00 Welcome (Alexandra Papadopoulou, Greece)

09.00 – 09.30 Epidemiology, clinical presentation and endoscopic findings in chilhood EoE (Alexandra Papadopoulou, Greece)
09.30 – 10.00 Histological findings in EoE. Histology scoring system EoEHSS (Fatima Carneiro, Portugal)
10.00 – 10.30 Oral immunotherapy induced esophageal eosinophilia - lessons to be learned (Noam Zevit, Israel)
10.30 – 11.00 Non invasive diagnostic tools in EoE: can they replace endoscopy? (Salvatore Oliva, Italy)
11.00 – 11.30 Coffee break

Chairs: Frédéric Gottrand; Michiel van Wijk

11.30 – 12.00 Online lecture: Esophageal dysmotility in EoE: which goes first? (Nikhil Thapar, Australia)
12.00 – 12.30 EoE in patients with esophageal atresia: how common is it and how its treatment affects the underlying disease? (Frédéric Gottrand, France)
12.30 – 13.00 The use of high resolution manometry, mucosal impedance and Endoflip in the diagnosis and follow up of EoE (Michiel van Wijk, the Netherlands)
13.00 – 14.00 Lunch

Chairs: Rok Orel; Carolina Gutierrez

14.00 – 14.30 Dietary or drug treatment for induction in EoE? How to choose the best treatment for the individual patient? (Noam Zevit, Israel)
14.30 – 15.00 Individualized approach to maintenance treatment: how and for how long? (Rok Orel, Slovenia)
15:00 – 15:30 Novel treatment modalities for resistant EoE (Carolina Gutierrez, Spain)
15.30 – 16.00 Patients' perspectives on EoE (Amanda Cordell, UK)
16.00 – 16.30 Coffee break

Chairs: Jorge Amil Dias; Salvatore Oliva

16.30 – 17.00 Online lecture: The role of eosinophils in the GI dysfunction:  are they key players or are they merely biomarkers? (Glenn Furuta, USA)
17.00 – 17.30 Online lecture: Pathogenic mechanisms of the various EGID (Marc Rothenberg, USA) 
17.30 – 18.00 Online lecture: Atopic comorbidities in patients with EGIDs: how do they affect the management? (Glenn Furuta, USA)
18:00 – 18:30 Clinical case discussion (Noam Zevit, Israel)
19.00 Dinner

Day 02 - Friday, November 05

Chairs: Noam Zevit; Rok Orel

09.00 – 09.30  Epidemiology, clinical presentation and endoscopic findings in childhood EGID beyond EoE (Alexandra Papadopoulou, Greece)
09.30 – 10.00 Initial work up of patients with suspected EGID beyond the esophagus (Rok Orel, Slovenia)
10.00 – 10.30 The role of US, MRI, MRE, CT scan and of full thickness biopsy in diagnosing muscular and serosal EGID phenotypes (Salvatore Oliva, Italy)
10.30 – 11.00 Histological criteria for diagnosing EGID beyond the esophagus (Fatima Carneiro, Portugal)
11.00 – 11.30 Coffee-break

Chairs: Sibylle Koletzko; Matthieu Groh

11.30 – 12.00 Eosinophilic colitis: can we always be certain about the diagnosis? Signs and symptoms suggesting IBD (Sibylle Koletzko, Germany)
12.00 – 12.30 Hypereosinophilic syndrome: how easy it is to differentiate from EGIDs?  Criteria for its diagnosis (Guillaume Lefevre, France) 
12.30 – 13.00 Connective Tissue Diseases. Associations with EGIDs (Matthieu Groh, France)
13.00 – 13.30 Lunch

Chairs: Marcus Auth; Salvatore Oliva

13.30 – 14.00 Drug treatment for induction in EGIDs (Salvatore Oliva, Italy)
14.00 – 14.30 Online lecture: Drug treatment beyond induction in EGIDs (Glenn Furuta, USA)
14.30 – 15.00 Elimination diets for treating EGIDs : which diet for which patient and for how long? (Marcus Auth, UK)
15.00 – 15.30 Treatment strategies for maintenance in EGID (Carolina Gutierrez, Spain)
15.30 – 16.00 Unmet needs of patients with EGIDs. Patient-Reported Outcomes are necessary (Marcus Auth, UK)
16.00 –  16.30 Coffee break

Chairs: Jorge Amil Dias; Carolina Gutierrez 

16.30 – 17.00 Clinical case discussion – interactive (Salvatore Oliva, Italy)
17.00 – 17.30 Online lecture: Novel therapies for refractory or resistant disease (Evan Dellon, USA)
17.30 – 18.30 Clinical cases discussion - interactive (Jorge Amil Dias, Portugal ;  Sibylle Koletzko, Germany ; Marcus Auth, UK) Three cases - 20 min each case
18.30 – 19.00 Eosinophil activation in Functional Gastrointestinal Disorders (Jorge Amil Dias, Portugal)
19.30 Farewell dinner

Day 03 - Saturday, November 06

Chairs: Berthold Koletzko; Frédéric Gottrand

09.00 – 09.30 Nutritional implications of elimination diets (Berthold Koletzko, Germany)
09.30 – 10.00 Three different Guidelines on EoE (UEG, AGA, ESPGHAN): do they differ, where and why? (Frédéric Gottrand, France)
10.00 – 10.30 ESPGHAN Guidelines on EoE 2021 (Jorge Amil Dias, Portugal)
10.30 – 11.00 Course assessment and closing remarks (Alexandra Papadopoulou, Greece)
12.00 Departure


Course Director: Hon. Prof. Dr. med.  Alexandra Papadopoulou (Athens, Greece)

Course faculty:

Alexandra Papadopoulou (Greece)
Berthold Koletzko (Germany)
Carolina Gutierrez (Spain)
Evan Dellon (USA)
Fatima Carneiro (Portugal)
Frédéric Gottrand (France)
Glenn Furuta (USA)
Guillaume Lefevre (France)
Jorge Amil Dias (Portugal)
Marc Rothenberg (USA)
Marcus Auth (UK)
Matthieu Groh (France)
Michiel van Wijk (the Netherlands)
Nikhil Thapar (Australia)
Noam Zevit (Israel)
Rok Orel (Slovenia)
Salvatore Oliva (Italy)
Sibylle Koletzko (Germany)

EoE patients organization: Amanda Cordell (UK)

Cost Coverage

ESPGHAN will arrange and cover the following for registered delegates: 

  • Dinners and social programme  (arranged by ESPGHAN)
  • Catering throughout the course   
  • Course Material 

Travel and accommodation should be covered by the delegates



ESPGHAN would like to thank our EPP partners for their support.

The EPP partners for 2021 can be found here



If you have any questions, please contact the ESPGHAN Office for details.
Phone: +41 (0)22 9000 401